Clinical Course of Unilateral Moyamoya Disease
- PMID: 32710766
- DOI: 10.1093/neuros/nyaa284
Clinical Course of Unilateral Moyamoya Disease
Abstract
Background: The natural history of unilateral moyamoya disease (MMD) progressing to bilateral MMD remains an enigma in modern vascular neurosurgery. Few, small series with limited follow-up have reported relatively high rates of contralateral stenosis progression.
Objective: To review our large series of unilateral MMD patients and evaluate radiographic and surgical progression rates, and identify any factors associated with progression.
Methods: We included all unilateral MMD cases treated from 1991 to 2017 in an observational study. We examined time to contralateral radiographic progression and contralateral progression requiring surgery. Using Cox regression analysis, we evaluated factors potentially associated with contralateral progression.
Results: There were 217 patients treated for unilateral MMD. About 71% were female, and the average age at first surgery was 33.8 yr. Average follow-up was 5.8 yr (range 1-22 yr). A total of 18 patients (8.3%) developed contralateral progression. And 8 of these (3.7%) developed progression requiring bypass surgery. Baseline stenosis and hyperlipidemia (HLD) were significantly associated with radiographic progression (hazard ratio [HR] = 9.7, P = .006; HR = 4.0, P = .024). Baseline stenosis was associated with surgical progression (HR = 44.2, P = .002). Results were similar when controlling for possible confounders using multivariate regression.
Conclusion: Previous series showed relatively high rates of progression in unilateral MMD (15%-30%), but these studies were small and long-term follow-up was rarely available. Our large series indicates that the rate of progression is lower than previously reported but still warrants yearly noninvasive screening. These data may provide indirect support for statin therapy in MMD.
Keywords: Clinical course; Moyamoya disease; Natural history; Unilateral moyamoya.
Copyright © 2020 by the Congress of Neurological Surgeons.
Comment in
-
Commentary: Clinical Course of Unilateral Moyamoya Disease.Neurosurgery. 2020 Nov 16;87(6):E636-E637. doi: 10.1093/neuros/nyaa293. Neurosurgery. 2020. PMID: 32710783 No abstract available.
Similar articles
-
The contralateral progression in a cohort of Chinese adult patients with unilateral moyamoya disease after revascularization: a single-center long-term retrospective study.Acta Neurochir (Wien). 2022 Jul;164(7):1837-1844. doi: 10.1007/s00701-022-05153-6. Epub 2022 Mar 26. Acta Neurochir (Wien). 2022. PMID: 35347450 Free PMC article.
-
Progression of unilateral moyamoya disease: A clinical series.Cerebrovasc Dis. 2006;22(2-3):109-15. doi: 10.1159/000093238. Epub 2006 May 9. Cerebrovasc Dis. 2006. PMID: 16685122
-
An epidemiological survey of moyamoya disease, unilateral moyamoya disease and quasi-moyamoya disease in Japan.Clin Neurol Neurosurg. 2013 Jul;115(7):930-3. doi: 10.1016/j.clineuro.2012.09.020. Epub 2012 Oct 4. Clin Neurol Neurosurg. 2013. PMID: 23041378
-
Technical evolution of pediatric neurosurgery: moyamoya disease.Childs Nerv Syst. 2023 Oct;39(10):2819-2827. doi: 10.1007/s00381-023-06017-9. Epub 2023 Jul 3. Childs Nerv Syst. 2023. PMID: 37395784 Review.
-
Moyamoya disease: a summary.Neurosurg Focus. 2009 Apr;26(4):E11. doi: 10.3171/2009.1.FOCUS08310. Neurosurg Focus. 2009. PMID: 19335127 Review.
Cited by
-
Psychiatric manifestations in moyamoya disease: more than a puff of smoke? a systematic review and a case-reports meta-analysis.Front Psychiatry. 2024 Mar 21;15:1371763. doi: 10.3389/fpsyt.2024.1371763. eCollection 2024. Front Psychiatry. 2024. PMID: 38585478 Free PMC article.
-
Potential predictors for progression of moyamoya disease: A systematic review and meta-analysis.Front Neurol. 2023 Mar 2;14:1128338. doi: 10.3389/fneur.2023.1128338. eCollection 2023. Front Neurol. 2023. PMID: 36937514 Free PMC article.
-
Infarction Patterns and Recurrent Adverse Cerebrovascular Events in Moyamoya Disease.Dis Markers. 2022 Mar 29;2022:8255018. doi: 10.1155/2022/8255018. eCollection 2022. Dis Markers. 2022. PMID: 35392499 Free PMC article.
-
Nationwide Cohort observational study on the safety and efficacy of COVID-19 vaccination in patients with Moyamoya disease.Sci Rep. 2024 Oct 17;14(1):24400. doi: 10.1038/s41598-024-73940-5. Sci Rep. 2024. PMID: 39420039 Free PMC article.
-
Progression of initially unilateral Moyamoya angiopathy in Caucasian Europeans.J Neurol. 2023 Sep;270(9):4415-4422. doi: 10.1007/s00415-023-11793-0. Epub 2023 Jun 1. J Neurol. 2023. PMID: 37261501
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
